Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.21.1
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 30, 2021
Mar. 15, 2021
Mar. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Feb. 23, 2021
Class of Stock [Line Items]            
Proceeds from issuance for conversion of common stock     $ 16,190,000      
Fair value adjustment of warrants     $ (214,000)    
Preferred Stock Warrants [Member]            
Class of Stock [Line Items]            
Number of preferred shares exchanged     43,107      
Merger Agreement [Member]            
Class of Stock [Line Items]            
[custom:WarrantsAndRightsIssued-0]     $ 2,157,686      
Merger Agreement [Member] | Investor [Member]            
Class of Stock [Line Items]            
Warrants to purchase common stock           143,890
Warrants exercise price per share           $ 5.9059
Fair value adjustment of warrants     214,000      
Fair value of warrants     $ 421,000      
Series A Convertible Preferred Stock [Member]            
Class of Stock [Line Items]            
Temporary Equity, Shares Outstanding     0   4,611,587  
Number of preferred shares exchanged         5,973,509  
Series B Convertible Preferred Stock [Member]            
Class of Stock [Line Items]            
Temporary Equity, Shares Outstanding     0   3,489,470  
Number of preferred shares exchanged     235,877   4,524,171  
Proceeds from issuance for conversion of common stock     $ 1,250,000      
Series B Convertible Preferred Stock [Member] | Merger Agreement [Member] | Cancer Genetics Inc [Member]            
Class of Stock [Line Items]            
Proceeds from issuance for conversion of common stock   $ 2,000,000.0        
Series C Convertible Preferred Stock [Member]            
Class of Stock [Line Items]            
Temporary Equity, Shares Outstanding     0   0  
Series C Convertible Preferred Stock [Member] | Merger Agreement [Member] | Cancer Genetics Inc [Member]            
Class of Stock [Line Items]            
Number of preferred shares exchanged 699,395